TrialFrontiers in immunology2022

ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk.

Maria Tsilika et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.